Alemtuzumab 12714-0085
Product NDC
12714-0085- Manufacturer
- Boehringer Ingelheim Pharma Gmbh And Co. Kg
- Dosage Form
- Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- May 7, 2001
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Alemtuzumab | 30 mg/30mg |
Packaging Options(1)
30 mg in 1 VIAL, SINGLE-DOSE (12714-085-30)